Simulations Plus, Inc. (SLP) Stock

Simulations Plus, Inc. (SLP) is a Technology stock trading at $18.23 (as of 2026-06-18), with a market capitalization of $345.72M and a trailing P/E of -5.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Simulations Plus, Inc. provides software and related services for drug discovery and development, using modeling and simulation to predict molecular and pharmacology properties. Its offerings include products such as GastroPlus, DILIsym, and chemistry- and pharmacokinetics-focused prediction and modeling suites, serving researchers and organizations worldwide.

Valuation — source: SEC EDGAR (first-party)
Price	$18.23
Market Cap	$345.72M
P/E Ratio	-5.5
EV / EBITDA	-5.3
Price / Book	2.58
Price / Sales	4.29
Dividend Yield	0.0%
DCF Value (model)	$13.54
DCF Upside vs Price	-25.7%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$79.18M
Net Margin	-81.7%
Return on Equity	-46.9%
Current Ratio	5.47
Revenue Growth (YoY)	13.1%
EPS Growth (YoY)	-744.0%
FCF Growth (YoY)	36.5%

Financial Health — source: SEC EDGAR
Altman Z-Score	29.76 (safe)

Valuation vs Sector & Industry
Stock P/E	-5.5
Sector P/E (Technology)	32.6
Industry P/E (Computers)	31.3
vs Sector	-116.8%
vs Industry	-117.5%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	First Light Asset Management, LLC ($31.12M)
Institutional Holders Tracked	10

Company
Sector	Technology
Industry	Computers
CEO	Shawn O'Connor
Employees	243
Country	US
IPO Date	1997-06-18

Related Companies (Business model: SaaS / Subscription Software (Enterprise); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.